What this instrument does
The Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Amendment Instrument 2026 amends the earlier Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025. The 2025 instrument dealt with what pharmacists can do when clonidine - a medicine used to treat conditions such as high blood pressure and ADHD - is in short supply, including substituting an equivalent product.
Key dates
- Registered: 23 April 2026
- Expires: 18 August 2026
Legislative framework
The instrument operates under the Therapeutic Goods Act 1989 and is administered by the Department of Health, Disability and Ageing.
What the amendment changes
The source document does not specify the exact changes the amendment makes to the 2025 instrument. The full instrument is available at https://www.legislation.gov.au/F2026L00447.
Key actions
- Pharmacies and businesses that dispense medicines can check the full instrument at https://www.legislation.gov.au/F2026L00447 to see what changes apply to clonidine substitution rules before 18 August 2026.
- Businesses for which clonidine is relevant can monitor the Department of Health, Disability and Ageing for further updates after the instrument expires on 18 August 2026.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.